These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1778080)

  • 1. Schizophrenic patients with depression: psychopathological profiles and relationship with negative symptoms.
    Lindenmayer JP; Grochowski S; Kay SR
    Compr Psychiatry; 1991; 32(6):528-33. PubMed ID: 1778080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the concurrent validity of the Calgary Depression Scale for Schizophrenics (CDSS).
    Lançon C; Auquier P; Reine G; Bernard D; Toumi M
    J Affect Disord; 2000 May; 58(2):107-15. PubMed ID: 10781700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression.
    Sax KW; Strakowski SM; Keck PE; Upadhyaya VH; West SA; McElroy SL
    Br J Psychiatry; 1996 Jan; 168(1):68-71. PubMed ID: 8770431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in schizophrenia: a comparison of three measures.
    Collins AA; Remington G; Coulter K; Birkett K
    Schizophr Res; 1996 May; 20(1-2):205-9. PubMed ID: 8794511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
    Langlois-Thery S; Dollfus S; Lesieur P; Petit M
    Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsyndromes of chronic schizophrenia: a phenomenological study.
    Arora A; Avasthi A; Kulhara P
    Acta Psychiatr Scand; 1997 Sep; 96(3):225-9. PubMed ID: 9296554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the Calgary Depression Scale for schizophrenics.
    Addington D; Addington J; Maticka-Tyndale E
    Schizophr Res; 1994 Feb; 11(3):239-44. PubMed ID: 8193062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale.
    Addington D; Addington J; Atkinson M
    Schizophr Res; 1996 May; 19(2-3):205-12. PubMed ID: 8789919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia.
    Sarró S; Dueñas RM; Ramírez N; Arranz B; Martínez R; Sánchez JM; González JM; Saló L; Miralles L; San L
    Schizophr Res; 2004 Jun; 68(2-3):349-56. PubMed ID: 15099616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Japanese version of the Calgary Depression Scale for Schizophrenics.
    Kaneda Y; Fujii A; Ohmori T
    J Nerv Ment Dis; 2000 Apr; 188(4):237-9. PubMed ID: 10790002
    [No Abstract]   [Full Text] [Related]  

  • 11. Interrater reliability of the Structured Clinical Interview for the Positive and Negative Syndrome Scale for schizophrenia.
    Lindström E; Wieselgren IM; von Knorring L
    Acta Psychiatr Scand; 1994 Mar; 89(3):192-5. PubMed ID: 8178678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standardized assessment of psychopathology by relatives of mentally disordered patients. Preliminary results of using the positive and negative syndrome scale to compare schizophrenic and affective disorders.
    Nitsche I; Kallert TW
    Psychopathology; 2007; 40(4):242-53. PubMed ID: 17440287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calgary Depression Scale for Schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients.
    Bernard D; Lançon C; Auquier P; Reine G; Addington D
    Acta Psychiatr Scand; 1998 Jan; 97(1):36-41. PubMed ID: 9504701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia.
    Peralta V; Cuesta MJ
    Psychiatry Res; 1994 Jul; 53(1):31-40. PubMed ID: 7991730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity study of the Brazilian version of the Calgary Depression Scale for Schizophrenia.
    Bressan RA; Chaves AC; Shirakawa I; de Mari J
    Schizophr Res; 1998 Jun; 32(1):41-9. PubMed ID: 9690333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural differences within negative and depressive syndrome dimensions in schizophrenia, organic brain disease, and major depression: A confirmatory factor analysis of the positive and negative syndrome scale.
    Eisenberg DP; Aniskin DB; White L; Stein JA; Harvey PD; Galynker II
    Psychopathology; 2009; 42(4):242-8. PubMed ID: 19451757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients].
    Schneider F; Böser H; Heimann H; Fus I; Friedrich J
    Wien Klin Wochenschr; 1992; 104(3):51-5. PubMed ID: 1570706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression dexamethasone nonsuppression and negative symptoms in schizophrenia.
    Addington D; Addington J
    Can J Psychiatry; 1990 Jun; 35(5):430-3. PubMed ID: 2372754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder.
    Emsley RA; Oosthuizen PP; Joubert AF; Roberts MC; Stein DJ
    J Clin Psychiatry; 1999 Nov; 60(11):747-51. PubMed ID: 10584762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.